16.7 C
Delhi
Thursday, February 22, 2024

Elon Musk’s Neuralink gets FDA approval for in-human clinical study

Date:

Share post:

Donate-GC-Razorpay

Los Angeles: Neuralink, Elon Musk’s brain-machine interface company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct its first in-human clinical study.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company tweeted.

Neuralink said recruitment for its clinical trial “is not open yet.”

The FDA has not commented on the trial. And the extent of the approved trial is not known yet.

Neuralink was founded in 2016 and funded primarily by Musk to develop a new kind of interface technology between the human brain and computing devices.

Installing a chip in the human skull could restore limb function, improve human movement, resolve issues with eyesight and hearing, and help with diseases like Parkinson’s, the company claims.

Related articles

Alwar ‘beef mandi’ case: FIR registered against Khalid, Aslam, Saddam and others

After the Rajasthan police busted an illegal ‘beef mandi’ being operated on an illegally encroached government land in...

India and Greece heading towards doubling bilateral trade by 2030: PM Modi

New Delhi: Prime Minister Narendra Modi on Wednesday held bilateral talks with his Greek counterpart Kyriakos Mitsotakis in...

Demand for removal of K K Pathak rocks Bihar Assembly

Patna: Bihar Chief Minister Nitish Kumar lost his cool over the demands of the opposition for removal of...

Target of CD ratio should be 65 pc next year: Yogi

Lucknow: Chief Minister Yogi Adityanath on Wednesday expressed his satisfaction with the state's current credit-deposit (CD) ratio of...